1182
Vol. 59, No. 9
Table 1. 1H- (600 MHz) and 13C-NMR (150 MHz) Data of Compounds 3
and 4 (Pyridine-d5)
fied fungi were stored in the PDA slant at 4 °C.
Culture Media The preliminary screening experiment was carried out
in liquid PDA medium (consisting of 200 g potatoes boiling for 20 min; dex-
trose, 20 g; peptone, 10 g; distilled H2O, 1000 ml).
3
4
No.
Identification of Endophytic Fungus The fungus was identified by se-
quencing the internal transcribed region of ribosome deoxyribonucleic acid
(rDNA-ITS). The universal primers ITS1 OF (5ꢄ-AACTCGGCCATTTA-
GAGGAAGT-3ꢄ) and ITS4 OF (5ꢄ-TCCTCCGCTTATTGATATGC-3ꢄ) were
used to amplify the ITS regions from the DNA extract.14) The polymerase
chain reaction (PCR) reaction was performed with the following cycles: (1)
94 °C for 3 min; (2) 30 cycles of 94 °C for 30 s, 55 °C for 30 s and 72 °C for
1 min, and (3) 72 °C for 10 min.
dH
dC
dH
dC
1
2
3
4
5
1.86 (o), 0.96 (m)
1.92 (o)
3.49 (m)
38.8 3.85 (dd, 4.2, 10.8)
28.7 2.35 (o), 2.39 (o)
78.2 3.61 (dd, 5.6, 12.6)
80.2
39.7
75.9
0.1
—
39.7
—
1.05 (m)
2.08 (o)
4.25 (dd, 4.2, 10.8)
53.3 0.84 (o)
30.0 1.67 (o), 1.71 (o)
73.2 1.13 (o), 1.44 (o)
43.8
53.4 2.49 (o)
37.1
130.3 5.65 (dd, 2.4, 10.8) 128.2
133.3 7.89 (d, 10.8)
90.1
48.0
53.0
18.3
31.9
42.7
54.9
43.2
6
7
8
9
10
11
12
13
14
Fermentation of Compound and Extraction of Metabolites. Prelimi-
nary Screening The preliminary screenings were carried out in 100 ml Er-
lenmeyer flasks containing 40 ml of liquid PDA medium. After incubation at
28 °C and 160 rpm in the shaker for 2 d, the substrate 0.5 mg (dissolved in
ethanol) were added into the flaks for another 10 d and harvested. Substrate
controls with the substrate but without fungi and culture controls with the
fungi but without substrate were incubated at the same conditions described
as above. The cultures were extracted with ethyl acetate for 40 min at ultra-
sonic condition. The extracts were evaporated under reduced pressure on a
rotary evaporator (50 °C) and then checked by TLC plates. The controls with
the substrate but without fungi and the controls with the fungi but without
substrate were incubated at the same conditions described as above.
Preparative Fermentation The preparative fermentation was carried
out according to standard two-stage fermentation. The seed cultures were
grown in 250 ml flasks each containing 100 ml of medium. 2% of the seed
cultures were added fifteen 1000 ml flask that contains 400 ml liquid PDA
media and several grains of glass beads which can increase the oxygen.
After 3 d, 800 mg substrate ursolic acid (suspended in ethanol : DMSOꢁ1 : 1)
were distributed evenly in fifteen flasks. The cultures were further incubated
for 10 d and then harvested. Mycelia were filtered and were ultrasonic ex-
tracted with ethyl acetate 40 min (3 times). The aqueous layer was extracted
with the equal volumes of the same solvent for 3 times. Both extracts were
combined and evaporated under reduced pressure on a rotary evaporator
(50 °C) and 490 mg crude extracts were obtained.
—
—
2.06 (o)
—
5.75 (dd, 1.2, 10.2)
6.05 (br d, 10.8)
—
—
139.4
89.9
42.9
26.4
23.6
45.6
60.7
38.6
40.7
31.4
32.3
28.8
16.1
15.5
20.2
16.7
179.9
18.1
19.5
—
—
—
15 1.25 (o)
30.5 1.81 (o), 1.19 (o)
1.41 (o), 2.22 (td, 4.8, 12.6) 23.8 2.15 (o),1.38 (o)
— 45.6
1.71 (d, 12.0)
16
17
18
—
61.2 1.65 (d, 12.6)
39.6 1.81 (m)
40.8 0.75 (o)
31.4 1.43 (o)
32.4 1.85 (o), 1.90 (o)
29.9 1.25 (o)
16.3 1.10 (s)
15.5 1.29 (o)
15.5 1.36 (s)
17.0 1.29 (o)
19 1.83 (o)
20 0.78 (o)
21 1.42 (o)
22 1.88 (o)
23 1.25 (s)
24 1.04 (o)
25 0.98 (s)
26 1.56 (s)
27 1.40 (o)
28
—
180.0
18.3 0.99 (d, 6.0)
18.4 0.86 (d, 6.0)
—
29
30
1.05 (d, 6.6)
0.88 (o)
Isolation of the Metabolites The crude residue (490 mg) was first puri-
fied by column chromatography on silica gel (200—300 mesh, 21 g) eluted
with a stepwise petroleum ether/acetone from 100 : 1 to 1 : 1. Two fractions
were obtained: fraction A (101 mg), B (60 mg). Fraction A was further puri-
fied by column chromatography on silica gel (300—400 mesh, 7 g) eluted
with a stepwise petroleum ether/acetone from 10 : 1 to 8 : 1 to afford metabo-
lite 2 (5 mg), and eluted with a stepwise dichloromethane /methanol from
90 : 1 to 60 : 1 to afford metabolite 3 (4 mg). Fraction B was further purified
by column chromatography on silica gel (100—200 mesh, 12 g) eluted with
a stepwise trichloromethane/methanol from 3 : 1 to 1 : 1 to afford metabolite
4 (7 mg).
Chemical shifts: ppm; coupling constants: Hz; Mult, multiplicity: s, singlet; d,
doublet; t, triplet; o, overlap. Assignments were based on 1H-NMR, 13C-NMR, APT,
HMQC and HMBC experiments.
References
1) Wilson D., Oikos, 73, 274—276 (1995).
2) Shrestha K., Strobel G. A., Shrivastava S. P., Gewali M. B., Planta
Med., 67, 374—376 (2001).
3) Chakravarthi B. V., Das P., Surendranath K., Karande A. A.,
Jayabaskaran C., J. Biosci., 33, 259—267 (2008).
4) Puri S. C., Nazir A., Chawla R., Arora R., Riyaz-Ul-Hasan S., Amna
T., Ahmed B., Verma V., Singh S., Sagar R., Sharma A., Kumar R.,
Rakesh K. S., Ghulam N. Q., J. Biotechnol., 122, 494—510 (2006).
5) Kour A., Shawl A. S., Rehman S., Sultan P., Parvaitz H. Q., Qazi P. H.,
Suden P., Khajuria R. K., Verma V., World J. Microbiol. Biotechnol.,
24, 1115—1121 (2006).
6) Wu S. H., Chen Y. W., Qin S., Huang R., J. Basic Microbiol., 48,
140—142 (2008).
7) Feng X., Zou Z. M., Fu S. B., Sun L. Z., Su Z. H., Sun D. A., J. Mol.
Catal., B Enzym., 66, 219—223 (2010).
8) Baricevic D., Sosa S., Della Loggia R., Tubaro A., Simonovska B.,
Krasna A., Zupancic A., J. Ethnopharmacol., 75, 125—132 (2001).
9) Fontanay S., Grare M., Mayer J., Finance C., Duval R. E., J.
Ethnopharmacol., 120, 272—276 (2008).
10) Novotny´ L., Vachálková A., Biggs D., Neoplasma, 48, 241—246
(2001).
11) Mezzeti T., Orzalesi G., Bellavita V., Planta Med., 20, 244—252
(1971).
12) Ju J. H., Zhou L., Lin G., Liu D., Wang L. W., Yang J. S., Chin. Pharm.
J., 38, 752—757 (2003).
Product 2: White solid, mp 236—237 °C, ESI-MS: m/z: 455 [MꢀH]ꢀ
,
1
931 [2MꢀNa]ꢀ, H-NMR (C5D5N): 0.77 (3H, s), 0.89 (3H, s), 0.97—0.98
(6H, o), 1.04 (3H, (3H, s), 0.92 (3H, s), 1.14 (3H, s), 3.20 (m), 5.51 (1H, dd,
Jꢁ10.8, 4.8 Hz, 11-H), 5.94 (1H, d, Jꢁ10.8 Hz, 12-H); 13C-NMR (C5D5N):
38.5 (C-1), 23.5 (C-2), 78.3 (C-3), 39.9 (C-4), 55.4 (C-5), 18.3 (C-6), 31.9
(C-7), 42.4 (C-8), 53.7 (C-9), 37.0 (C-10), 130.0 (C-11), 134.1 (C-12), 89.8
(C-13), 42.6 (C-14), 28.2 (C-15), 26.2 (C-16), 45.5 (C-17), 60.8 (C-18), 38.9
(C-19), 40.7 (C-20), 21.3 (C-21), 32.3 (C-22), 28.7 (C-23), 16.2 (C-24), 16.5
(C-25), 19.5 (C-26), 18.6 (C-27), 179.8 (C-28), 18.5 (C-29), 19.7 (C-30).
Product 3: White solid, mp 269—270 °C, [a]D20 ꢀ5.3° (cꢁ0.75, MeOH),
UV lmax (MeOH): 203 nm; IR (KBr) cmꢂ1: 3446, 3421, 2951, 2925, 2869,
2856, 1759, 1457, 1387, 1219. HR-ESI-MS: m/z: 469.3333 [MꢀH]ꢀ,
1
(Calcd for C30H45O4, 469.3312). H-NMR (500 MHz, pyridine-d5) and 13C-
NMR (150 MHz, pyridine-d5) see Table 1.
Product 4: White solid, mp 274—277 °C, [a]D20 ꢀ70.6° (cꢁ0.11, MeOH),
UV lmax (MeOH): 205 nm; IR (KBr) cmꢂ1: 3546, 3437, 2969, 2951, 2933,
2868, 1757, 1467, 1387, 1360, 1220. HR-EI-MS: m/z: 470.3365 [M]ꢀ,
1
(Calcd for C30H46O4, 470.3396). H-NMR (500 MHz, pyridine-d5) and 13C-
NMR (150 MHz, pyridine-d5) see Table 1.
Acknowledgements This work is financially supported by the National
Nature Science Foundation of China (Project No. 20772158) and the New
Drug Development Project of China (Project No. 2009ZX09301-003).
13) Strobel G., Yang X., Sears J., Kramer R., Sidhu R. S., Hess W. M., Mi-
crobiology, 142, 435—440 (1996).
14) Taylor D. L., McCormick M. K., New Phytol., 177, 1020—1033
(2008).